EA200501413A1 - Местные композиции, содержащие l-карнитин - Google Patents

Местные композиции, содержащие l-карнитин

Info

Publication number
EA200501413A1
EA200501413A1 EA200501413A EA200501413A EA200501413A1 EA 200501413 A1 EA200501413 A1 EA 200501413A1 EA 200501413 A EA200501413 A EA 200501413A EA 200501413 A EA200501413 A EA 200501413A EA 200501413 A1 EA200501413 A1 EA 200501413A1
Authority
EA
Eurasian Patent Office
Prior art keywords
carnitine
skin
composition
acyl
present
Prior art date
Application number
EA200501413A
Other languages
English (en)
Russian (ru)
Inventor
Джакоб Гут
Майкл Фред Чучак
Вики Лентнер
Original Assignee
Лонца Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лонца Инк. filed Critical Лонца Инк.
Publication of EA200501413A1 publication Critical patent/EA200501413A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA200501413A 2003-03-28 2004-03-29 Местные композиции, содержащие l-карнитин EA200501413A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45882203P 2003-03-28 2003-03-28
PCT/US2004/009591 WO2004087072A2 (en) 2003-03-28 2004-03-29 Topical l-carnitine compositions

Publications (1)

Publication Number Publication Date
EA200501413A1 true EA200501413A1 (ru) 2006-10-27

Family

ID=33131830

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501413A EA200501413A1 (ru) 2003-03-28 2004-03-29 Местные композиции, содержащие l-карнитин

Country Status (13)

Country Link
US (1) US20050100519A1 (enExample)
EP (1) EP1610760A4 (enExample)
JP (1) JP2006522807A (enExample)
KR (1) KR20050113669A (enExample)
CN (1) CN1964695A (enExample)
AU (1) AU2004226324A1 (enExample)
BR (1) BRPI0408834A (enExample)
CA (1) CA2519998A1 (enExample)
EA (1) EA200501413A1 (enExample)
MX (1) MXPA05010417A (enExample)
NO (1) NO20054465L (enExample)
WO (1) WO2004087072A2 (enExample)
ZA (1) ZA200507824B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416869B2 (en) * 2004-08-19 2008-08-26 Lonza Ltd. Enzyme delivery systems, application in water based products
ITMI20041603A1 (it) * 2004-08-04 2004-11-04 Vama Farmacosmetica S R L Materia prima cosmetica a base di 1-carnitina per preparato ad effetto idratante di lunga durata e preparato cosmetico ottenuto con questa materia prima
EP1649846A1 (de) * 2004-10-21 2006-04-26 Neubourg Skin Care GmbH & Co. KG Verwendung von Harnstoff zur Behandlung von Altersflecken
KR101165848B1 (ko) * 2005-08-18 2012-07-13 (주)아모레퍼시픽 효소 및 아미노산을 함유하는 피부 화장료 조성물
KR101239344B1 (ko) 2006-05-19 2013-03-05 마리 케이 인코포레이티드 글리세릴 및 글리콜산 화합물
TW200831125A (en) * 2006-12-08 2008-08-01 Pola Chem Ind Inc A discrimination method of skin barrier function, the screening method of skin barrier function reinforced material by using the discrimination method, the skin barrier function reinforced materials, and the cosmetic material containing the skin barrier
BRPI0721698A2 (pt) * 2007-05-11 2013-01-22 Sigma Tau Ind Famaceutiche Riunite S P A gel étil para a liberaÇço de ingredientes ativos cosmÉticos
BRPI0921679A2 (pt) * 2008-11-11 2016-02-16 Sigma Tau Ind Farmaceuti composto útil para tratar celulite
KR101017586B1 (ko) * 2008-11-28 2011-02-28 (주)아모레퍼시픽 피부 미백용 화장료 조성물
FR2949969B1 (fr) * 2009-09-11 2012-08-03 Svr Lab Composition cosmetique a base d'uree pure, utilisation et procede d'application correspondant
DE102012214038A1 (de) * 2012-08-08 2014-02-13 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus Harnstoff und Car-ni-tin und/oder einem oder mehreren Acyl-Carnitinen zur Behandlung und Prophylaxe von Neurodermitis sowie des diabetischen Fußes
KR102158895B1 (ko) 2013-03-12 2020-09-22 마리 케이 인코포레이티드 보존 시스템
CA2950900A1 (en) * 2014-06-02 2015-12-10 Avon Products, Inc. Topical lightening composition and methods of use thereof
ES2815659T3 (es) 2014-08-18 2021-03-30 Pan Montojo Francisco El ácido glicólico mejora la motilidad del esperma
ES2910653T3 (es) * 2015-01-27 2022-05-13 Professional Dietetics S P A In Forma Abbreviata P D S P A Composiciones que comprenden a) quitosano, b) ácido glicólico, c) carnitina y/o n-acetilcisteína para el tratamiento de descamación dermoepidérmica
EP3641725A1 (en) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition and method for improving the appearance of skin
KR101934022B1 (ko) * 2017-12-04 2018-12-31 주식회사 엘지생활건강 피부 각질 박리 촉진용 화장용 조성물
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
WO2020017760A1 (ko) * 2018-07-17 2020-01-23 주식회사 엘지생활건강 각질 박리 증진용 화장료 조성물
KR102253135B1 (ko) * 2018-07-17 2021-05-17 주식회사 엘지생활건강 각질 박리 증진용 화장료 조성물
KR102771004B1 (ko) * 2018-10-17 2025-02-21 주식회사 엘지생활건강 피부 각질 박리 촉진용 화장료 조성물
CN109528628B (zh) * 2018-12-14 2022-02-08 北京中医药大学 一种包含左卡尼汀的药用组合物及其制备方法和用途
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JP7590462B2 (ja) 2020-06-01 2024-11-26 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法
WO2022115859A1 (en) * 2020-11-25 2022-06-02 Topix Pharmaceuticals, Inc. Scar treatment composition
EP4306100A4 (en) * 2021-03-08 2025-03-19 LG Household & Health Care Ltd. COSMETIC COMPOSITION COMPRISING CARNITINE SALICYLATE AS ACTIVE INGREDIENT
CN116981438A (zh) * 2021-03-08 2023-10-31 株式会社Lg生活健康 包含肉碱水杨酸盐作为有效成分的化妆料组合物
WO2025258571A1 (ja) * 2024-06-12 2025-12-18 大阪ガスケミカル株式会社 ターンオーバー促進剤およびその用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683939A (en) * 1970-05-28 1972-08-15 Wilson Pharm & Chem Corp Proteinaceous cosmetic material for hair conditioning
JPS51148042A (en) * 1975-06-14 1976-12-18 Kanebo Ltd Skin toiletry
US5389677B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
JPH0615462B2 (ja) * 1989-01-12 1994-03-02 レイコ 小阪 毛髪用組成物
IT1261984B (it) * 1993-06-22 1996-06-11 Avantgarde Spa Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
JPH07157409A (ja) * 1993-12-07 1995-06-20 Kobe Steel Ltd 美白性化粧料
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
JP3229517B2 (ja) * 1995-04-18 2001-11-19 カネボウ株式会社 美白化粧料
JPH09263514A (ja) * 1996-03-29 1997-10-07 Shiseido Co Ltd 皮膚外用剤
US5968528A (en) * 1997-05-23 1999-10-19 The Procter & Gamble Company Skin care compositions
JPH1129457A (ja) * 1997-07-04 1999-02-02 Kanebo Ltd 皮膚化粧料
JPH11180851A (ja) * 1997-12-22 1999-07-06 Kanebo Ltd 皮膚化粧料
DE19806946A1 (de) * 1998-02-19 1999-09-09 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
DE19806947A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Chinon und oder mindestens einem Hydrochinon sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
JP3229594B2 (ja) * 1998-12-16 2001-11-19 カネボウ株式会社 美白化粧料
JP3874966B2 (ja) * 1999-05-11 2007-01-31 株式会社カネボウ化粧品 シート状美白パック化粧料
US6416769B1 (en) * 2000-03-03 2002-07-09 Australian Importers, Ltd. Cosmetic compositions comprising exfoliating enzymes and uses thereof
WO2001082878A1 (en) * 2000-05-02 2001-11-08 Perricone Nicholas V Treatment of skin damage using acetyl carnitine and phosphatidylcholine and/or ascorbyl fatty acid esters
DE10129504A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe von Pigmentierungsstörungen
MXPA04004478A (es) * 2001-11-13 2004-08-11 Procter & Gamble Composiciones que contienen enzimas estabilizadas con ciertos osmoprotectores y metodos para utilizarls en el cuidado personal.

Also Published As

Publication number Publication date
EP1610760A4 (en) 2008-01-09
US20050100519A1 (en) 2005-05-12
NO20054465L (no) 2005-12-12
NO20054465D0 (no) 2005-09-27
AU2004226324A1 (en) 2004-10-14
JP2006522807A (ja) 2006-10-05
BRPI0408834A (pt) 2006-04-04
MXPA05010417A (es) 2005-11-04
CA2519998A1 (en) 2004-10-14
WO2004087072A2 (en) 2004-10-14
EP1610760A2 (en) 2006-01-04
KR20050113669A (ko) 2005-12-02
ZA200507824B (en) 2007-04-25
CN1964695A (zh) 2007-05-16
WO2004087072A3 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
MXPA05010417A (es) Composiciones topicas de l-carnitina.
ATE321525T1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
ATE245416T1 (de) Neue fettanaloge zur behandlung von diabetes
ATE309775T1 (de) Die verwendung von prostaglandin f analoga zur herstellung von zusammensetzungen für die behandlung von haarausfall.
ES2157684T3 (es) Composicion de blanqueo de la piel y/o de los cabellos.
BRPI0409624A (pt) 2-hidróxi-3-diaminoalcanos de benzamida
DE60219595D1 (de) Verfahren zur behandlung von erkrankungen mit malonyl coa-decarboxylase-inhibitoren
ATE384745T1 (de) Herstellung von polysaccharidbetainatverbindungen,hergestellte verbindungen, deren verwendung und diese enthaltenden zusammensetzungen
BR0010166A (pt) Composto modulador de ace-2, composto inibidor de ace-2, métodos para o tratamento de um estado associado a ace-2 em um paciente e para inibir a hidrólise de um peptìdeo de marcação de ace-2, e, composição farmacêutica
BR0008440A (pt) Inibidor de metaloprotease de sulfamato do ácido hidroxâmico
DE60133716D1 (de) Verwendungen eines getränks enthaltend ein polyphosphat zur behandlung von zahnerosionen
RU97112875A (ru) Модулирующая апоптоз композиция, содержащая фактор, оказывающий влияние на внутриклеточное содержание метионаля или диальдегида малоновой кислоты
EA200802172A1 (ru) Замещенные бифенилкарбоновые кислоты и их производные
IT1274156B (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
EP0955046B1 (en) Amino acid derivatives as anti-inflammatory agents
DE69806622D1 (de) Kosmetische formulierungen zur verhütung und behandlung von haarausfall
EA200501069A1 (ru) Состав для местного применения и способы обработки старческой или повреждённой воздействием окружающей среды кожи
DE60315238D1 (de) Verwendung eines Assoziates aus synergistischen Kalziumkanalblocker-Agentien zur Vermeidung oder Behandlung von Falten und feinen Linien
IT1274157B (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
BRPI0411455A (pt) composto, formulação farmacêutica, método de tratamento ou prevenção de distúrbios de lipìdeo, uso de um composto, método de tratamento de diabetes do tipo 2, e, composição farmacêutica
IT1320782B1 (it) Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
BR9916947A (pt) Composição cosmética desodorante contendo um composto inibidor de enzima de transformação dos ácidos aminados, processo para tratar os odores axilares humanos e uso de um composto inibidor de enzima de transformação dos ácidos aminados
DE69629282D1 (de) Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern
PL1722748T3 (pl) Kompozycje do pielęgnacji skóry zawierające kwasy salicylowe
AR024082A1 (es) Sales antitranspirantes y metodos para su preparacion